Frontlight ResearchEarly access
Metastatic breast cancer trials in Qatar
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in QatarBEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy
- Where
- Doha
- Age
- 18 years and over
- People
- 109 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07597993